← Back to Search

Other

Transcranial magnetic stimulation (TMS) for Generalized Anxiety Disorder (TINA Trial)

N/A
Waitlist Available
Led By Carmen Andreescu, MD
Research Sponsored by Carmen Andreescu
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and within 2 weeks post-tms intervention
Awards & highlights

TINA Trial Summary

This study is evaluating whether a brain stimulation technique can reduce worry in people with dementia.

Eligible Conditions
  • Generalized Anxiety Disorder

TINA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and the end of tms intervention (approximately two weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and the end of tms intervention (approximately two weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Worry Severity From Baseline to Post-intervention as Measured by the Penn State Worry Questionnaire (PSWQ)
Participants Who Responded to TMS

TINA Trial Design

1Treatment groups
Experimental Treatment
Group I: Transcranial magnetic stimulation (TMS)Experimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcranial magnetic stimulation (TMS)
2013
Completed Phase 4
~510

Find a Location

Who is running the clinical trial?

Carmen AndreescuLead Sponsor
Carmen Andreescu, MDPrincipal InvestigatorUniversity of Pittsburgh
1 Previous Clinical Trials
57 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~4 spots leftby Apr 2025